查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1578788

口服避孕藥市場：按類型、年齡層、類別、分佈 - 全球預測 2025-2030

Oral Contraceptive Pills Market by Type (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Category, Distribution - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年口服避孕藥市值為173.3億美元，預計到2024年將達到183.6億美元，複合年成長率為6.76%，到2030年將達到274.1億美元。

口服避孕藥 (OCP) 市場包括旨在避孕和管理荷爾蒙失衡的產品，包括防止排卵的雌激素和黃體素組合。對 OCP 的需求在於其在為女性提供生育選擇和有效管理多囊性卵巢症候群 (PCOS) 和子宮內膜異位症等疾病方面發揮的作用。 OCP 主要應用於女性健康領域，由醫療保健提供者、零售藥局和線上平台部署。最終用戶範圍從優先考慮便利和隱私的個人到專注於綜合女性健康服務的醫療保健系統。

主要市場統計
基準年[2023] 173.3億美元
預測年份 [2024] 183.6億美元
預測年份 [2030] 274.1億美元
複合年成長率（%） 6.76%

關鍵的成長要素包括避孕藥具意識和接受度的提高、支持計劃生育的社會規範的改變以及對更個人化醫療保健的需求迅速增加。專注於最大限度地減少副作用、延長保存期限以及提供口服藥物以外的選擇的技術創新帶來了巨大的機會。企業應利用數位健康領域的技術進步，為虛擬諮詢和個人化醫療提供平台。新興市場，尤其是都市化不斷提高、健康教育機會不斷增加的發展中地區，還有開拓的潛力。與醫療機構的策略聯盟進一步提高了市場滲透率和消費者信任度。

然而，該市場面臨一些限制，例如某些地區的道德和政治反對、長期使用相關的潛在健康風險以及阻礙用戶的副作用等。監管障礙也是一個重大挑戰，嚴格的核准常常會延後產品的發布。研究非荷爾蒙避孕方案並加深我們對荷爾蒙對不同族群影響的了解，為創新鋪路。最後，向永續性和環境責任的轉變，例如生物分解性包裝的開發，符合全球環境趨勢並開拓了新市場。平衡成長需要應對這些複雜性，同時跟上技術和監管進步的步伐。了解消費者回饋並相應調整您的策略可以極大地提高您的市場地位和成長預測。

市場動態：揭示快速發展的口服避孕藥市場的關鍵市場洞察

供需的動態交互作用正在改變口服避孕藥市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 意外懷孕導致收養人數增加
    • 政府和非政府組織為普及避孕藥具所做的努力
    • 性行為感染傳染病 (STD) 增加
  • 市場限制因素
    • 避孕藥對健康的不良影響
  • 市場機會
    • 口服避孕藥處方的進展
    • 透過遠端醫療服務和政府的有利核准改善避孕措施
  • 市場挑戰
    • 有關藥丸使用和產品行銷問題的安全和社會問題

波特五力：駕馭口服避孕藥市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解口服避孕藥市場的外部影響

外部宏觀環境因素在塑造口服避孕藥市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解口服避孕藥市場的競爭格局

對口服避孕藥市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣口服避孕藥市場供應商的績效評估

FPNV定位矩陣是評估口服避孕藥市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃口服避孕藥市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，口服避孕藥市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 意外懷孕導致收養增加
      • 政府和非政府組織努力普及避孕藥具
      • 性行為感染傳染病（STD）盛行率增加
    • 抑制因素
      • 避孕藥具對健康的不良影響
    • 機會
      • 口服避孕藥配方的進展
      • 透過遠端醫療服務和政府核准改善避孕措施
    • 任務
      • 有關錠劑使用和產品行銷問題的安全和社會問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章口服避孕藥市場：依類型

  • 複方丸
  • 延續/延長藥丸
  • 黃體酮丸

第7章口服避孕藥市場：依年齡層

  • 15-24
  • 25-34
  • 35-44
  • 45歲以上

第8章口服避孕藥市場：依類別

  • 品牌
  • 非專利的

第9章 口服避孕藥市場經銷商

  • 離線
  • 線上

第10章美洲口服避孕藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太口服避孕藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲口服避孕藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbvie Inc.
  • Acme Generics Pvt. Ltd.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma Limited
  • Azesto Impex Private Limited
  • Bayer AG
  • HLL Lifecare Limited
  • Insud Pharma
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Mankind Pharma Ltd.
  • Mayne Pharma Group Limited
  • Merck & Co. Inc.
  • Mithra Pharmaceuticals, SA
  • Mylan NV
  • Perrigo Company PLC
  • Pfizer Inc.
  • Piramal Pharma Solutions
  • Sanofi SA
  • Syzygy Healthcare Solutions LLC
  • Teva Pharmaceuticals Industries Ltd.
  • TherapeuticsMD, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4676B64E6B2E

The Oral Contraceptive Pills Market was valued at USD 17.33 billion in 2023, expected to reach USD 18.36 billion in 2024, and is projected to grow at a CAGR of 6.76%, to USD 27.41 billion by 2030.

The market for oral contraceptive pills (OCPs) encompasses products designed for birth control and the management of hormonal imbalances, involving combinations of estrogen and progestin hormones, which prevent ovulation. The necessities of OCPs lie in their role in empowering women with reproductive choice and effectively managing conditions such as polycystic ovary syndrome (PCOS) and endometriosis. Applied primarily by women's health segments, the expansion of these pharmaceuticals spans healthcare providers, retail pharmacies, and online platforms. End-use scope ranges from individual users, who prioritize ease and privacy, to healthcare systems focusing on comprehensive women's health services.

KEY MARKET STATISTICS
Base Year [2023] USD 17.33 billion
Estimated Year [2024] USD 18.36 billion
Forecast Year [2030] USD 27.41 billion
CAGR (%) 6.76%

Key growth influencers include increased awareness and acceptance of contraceptives, shifts in societal norms supporting family planning, and the burgeoning demand for more personalized medicine. Innovations focusing on minimizing side effects, extending the duration of effectiveness, or offering non-oral alternatives present significant opportunities. Companies should capitalize on technological advancements in the digital health space, offering platforms for virtual consultations and personalized medicine. Emerging markets, particularly in developing regions with increasing urbanization and better access to health education, offer untapped potential. Strategic alliances with healthcare bodies further streamline market penetration and consumer trust.

However, the market faces constraints such as ethical and political opposition in certain regions, potential health risks associated with long-term use, and side effects that can deter users. Regulatory hurdles also pose significant challenges, with stringent approvals often delaying product releases. Research into non-hormonal contraceptive options and furthering understanding of hormone impacts on diverse populations opens avenues for innovation. Lastly, shifting towards sustainability and environmental responsibility, such as developing biodegradable packaging, aligns with global environmental trends and opens new market niches. Balanced growth requires navigating these complexities while keeping pace with technological and regulatory evolutions. Understanding consumer feedback and adjusting strategies accordingly can vastly enhance market position and forecasted growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oral Contraceptive Pills Market

The Oral Contraceptive Pills Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising adoption owing to unintended pregnancies
    • Government and NGO initiatives to promote contraceptive pills
    • Increasing prevalence of sexually transmitted diseases (STDs)
  • Market Restraints
    • Adverse health impacts of contraceptive pills
  • Market Opportunities
    • Advancements in the formulations of oral contraceptive pills
    • Improving access to birth control with telehealth services and favourable government approvals
  • Market Challenges
    • Safety and social concerns regarding pill usage and issues with product marketing

Porter's Five Forces: A Strategic Tool for Navigating the Oral Contraceptive Pills Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oral Contraceptive Pills Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oral Contraceptive Pills Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oral Contraceptive Pills Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oral Contraceptive Pills Market

A detailed market share analysis in the Oral Contraceptive Pills Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oral Contraceptive Pills Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oral Contraceptive Pills Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oral Contraceptive Pills Market

A strategic analysis of the Oral Contraceptive Pills Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oral Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Acme Generics Pvt. Ltd., Afaxys, Inc., Agile Therapeutics, Inc., Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, Azesto Impex Private Limited, Bayer AG, HLL Lifecare Limited, Insud Pharma, Johnson & Johnson Services, Inc., Lupin Limited, Mankind Pharma Ltd., Mayne Pharma Group Limited, Merck & Co. Inc., Mithra Pharmaceuticals, SA, Mylan N.V., Perrigo Company PLC, Pfizer Inc., Piramal Pharma Solutions, Sanofi SA, Syzygy Healthcare Solutions LLC, Teva Pharmaceuticals Industries Ltd., TherapeuticsMD, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Oral Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Combination Pill, Continuous/Extended Pill, and Progesterone Pill.
  • Based on Age Group, market is studied across 15-24, 25-34, 35-44, and 45 and Above.
  • Based on Category, market is studied across Branded and Generic.
  • Based on Distribution, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption owing to unintended pregnancies
      • 5.1.1.2. Government and NGO initiatives to promote contraceptive pills
      • 5.1.1.3. Increasing prevalence of sexually transmitted diseases (STDs)
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impacts of contraceptive pills
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in the formulations of oral contraceptive pills
      • 5.1.3.2. Improving access to birth control with telehealth services and favourable government approvals
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and social concerns regarding pill usage and issues with product marketing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Oral Contraceptive Pills Market, by Type

  • 6.1. Introduction
  • 6.2. Combination Pill
  • 6.3. Continuous/Extended Pill
  • 6.4. Progesterone Pill

7. Oral Contraceptive Pills Market, by Age Group

  • 7.1. Introduction
  • 7.2. 15-24
  • 7.3. 25-34
  • 7.4. 35-44
  • 7.5. 45 and Above

8. Oral Contraceptive Pills Market, by Category

  • 8.1. Introduction
  • 8.2. Branded
  • 8.3. Generic

9. Oral Contraceptive Pills Market, by Distribution

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Americas Oral Contraceptive Pills Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Oral Contraceptive Pills Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Oral Contraceptive Pills Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbvie Inc.
  • 2. Acme Generics Pvt. Ltd.
  • 3. Afaxys, Inc.
  • 4. Agile Therapeutics, Inc.
  • 5. Amneal Pharmaceuticals LLC
  • 6. Aurobindo Pharma Limited
  • 7. Azesto Impex Private Limited
  • 8. Bayer AG
  • 9. HLL Lifecare Limited
  • 10. Insud Pharma
  • 11. Johnson & Johnson Services, Inc.
  • 12. Lupin Limited
  • 13. Mankind Pharma Ltd.
  • 14. Mayne Pharma Group Limited
  • 15. Merck & Co. Inc.
  • 16. Mithra Pharmaceuticals, SA
  • 17. Mylan N.V.
  • 18. Perrigo Company PLC
  • 19. Pfizer Inc.
  • 20. Piramal Pharma Solutions
  • 21. Sanofi SA
  • 22. Syzygy Healthcare Solutions LLC
  • 23. Teva Pharmaceuticals Industries Ltd.
  • 24. TherapeuticsMD, Inc.
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. ORAL CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
  • FIGURE 2. ORAL CONTRACEPTIVE PILLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ORAL CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ORAL CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ORAL CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ORAL CONTRACEPTIVE PILLS MARKET DYNAMICS
  • TABLE 7. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CONTINUOUS/EXTENDED PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTERONE PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY 15-24, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY 25-34, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY 35-44, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY 45 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 190. ORAL CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. ORAL CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023